Related Experiment Video
Updated: Jul 19, 2026
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
13.9K
Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis
B Perlman1, D Heller1,2, B Cracchiolo1
1a Departments of Obstetrics , Gynecology, and Women's Health, Rutgers-New Jersey Medical School , Newark , NJ , USA.
Climacteric : the Journal of the International Menopause Society
|October 18, 2016
Summary
Postmenopausal bleeding can occur with interferon beta-1b therapy, potentially due to elevated estradiol. Healthcare providers should be aware of this association for accurate diagnosis and management.
Area of Science:
- Neurology
- Endocrinology
- Gynecology
Background:
- Interferon beta-1b is a common treatment for multiple sclerosis.
- Postmenopausal bleeding requires evaluation for endometrial carcinoma, though benign causes exist.
- Rare cases of premenopausal bleeding have been linked to interferon beta-1b.
Observation:
- This study reports a case of postmenopausal bleeding in a patient receiving interferon beta-1b.
- A literature search revealed no prior reports of postmenopausal bleeding associated with this therapy.
Findings:
- The patient's postmenopausal bleeding was attributed to elevated serum estradiol levels.
- Interferon beta-1b therapy was associated with these elevated estradiol levels.
Implications:
- Awareness of this potential side effect is crucial for both patients and healthcare providers.
- This association may warrant further investigation into the endocrinological effects of interferon beta-1b.
- Prompt evaluation of postmenopausal bleeding in patients on interferon beta-1b is recommended.
Keywords:
Interferon-beta/adverse effectsInterferon-beta/therapeutic usemultiple sclerosis/drug therapypostmenopausal bleedingMore Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...